Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JCOG1008 postoperative chemoradiotherapy trial in high-risk head and neck squamous cell carcinoma
jRCTs031180135Phase 3Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoints: overall survival and proportion of treatment completion. Started Oct 2012; status: completed.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on jRCTs031180135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180135.